AstraZeneca’s AZD6793 holds potential to expand oral COPD treatment options, says GlobalData EP News Bureau Sep 15, 2026 At the European Respiratory Society (ERS) Congress 2026, AstraZeneca presented the design of the Phase IIb PRESTO trial, a large…
